Table of Contents

Locator Record

Title: Prescription Medications - Drug Information (RXQ_DRUG )
Contact Number: 1-866-441-NCHS
Years of Content: 1988 - 2010
First Published: August, 2007
Revised: May, 2012
Access Constraints: None
Use Constraints: None
Geographic Coverage: National
Subject:The Drug Information File provides the therapeutic drug classes associated with each drug and ingredient reported by a survey participant in the Prescription Medication Subsection of the Household Interview.
Record Source: NHANES 1988 - 2010
Survey Methodology: NHANES 1988 - 2010 is a stratified multistage probability sample of the civilian non-institutionalized population of the U.S.
Medium: NHANES Web site; SAS transport files

Component Description

The Drug Information File contains additional data on the prescription drug(s) reported by a survey participant in the Prescription Medication Subsection of the Household Interview. Specifically, it provides the therapeutic drug classes associated with each drug and ingredient.

NCHS used the Lexicon Plus®, a proprietary database of Cerner Multum, Inc. to assist with data collection, data editing and release. The Lexicon Plus is a comprehensive database of all prescription and some nonprescription drug products available in the U.S. drug market. Multum distributes the Lexicon Plus in Microsoft Access format and posts regular updates on its website.

In accordance with Multum’s license agreement (Appendix 1), NCHS publications, tabulations, and software applications should cite the Multum Lexicon as the source and basis for the coding and classification of the NHANES drug data.

For additional information on the Multum Lexicon Drug Database, please refer to the following Web site: http://www.multum.com/Lexicon.htm.

Data Processing and Editing

The December 2010 Multum Lexicon database was used for processing and editing the 2009-2010 prescription drug data and creating the RXQ_RX_F and RXQ_DRUG data release files.

RXDDRUG: Generic drug name

All reported drug names were converted to a standard generic drug name for data release. For multi-ingredient products, the ingredients are listed in alphabetical order (i.e., Acetaminophen; Codeine).

In some cases, medications were reported with insufficient detail to accurately identify the exact product. But there was still some information provided about the therapeutic class of the drug. These products have been released with the Multum Lexicon's therapeutic category name followed by "- unspecified" (e.g., anti-infective - unspecified, hormones/hormone modifiers - unspecified).

RXDDRGID: Generic drug code

Each generic drug name is associated with a unique generic drug code from Multum's Lexicon Drug Database. There were some drug names reported by NHANES' participants that were not found in the Drug Database. These have been assigned unique drug codes beginning with an "a" or "h". Unspecified products with known therapeutic action have drug codes beginning with a "c" and are followed by their respective Multum therapeutic category code.

RXDINGFL: Single/Multiple ingredient drug

This variable identifies whether the drug is composed of a single ingredient or multiple ingredients. RXDINGFL equals zero for "unspecified" drugs.

RXDDCI1A - RXDDCI4C: Multum drug therapeutic category id

RXDDCN1A - RXDDCN4C: Multum drug therapeutic category names

The Multum Lexicon provides a 3-level nested category system (Appendix 2, data file RXQ_DRUG) that assigns a therapeutic classification to each drug and each ingredient of the drug (e.g., for naproxen: central nervous system agents [level 1]; analgesics [level 2]; nonsteroidal anti-inflammatory agents [level 3]). Not all drugs have three classification levels; some may only have two classification levels [e.g., for losartan: cardiovascular agents [level 1]; angiotensin II inhibitors [level 2]). Others only have one classification level.

The variables RXDDCI1A to RXDDCI4C record the unique Multum drug category id, which is a numeric value from 1 to 433. The variables RXDDCN1A to RXDDCN4C record the corresponding Multum drug category name, which is a text entry. Variable names ending in 'A' are associated with level 1 therapeutic categories, those ending in 'B' are associated with level 2, and those ending in 'C' are associated with level 3.

A drug may have up to four drug therapeutic categories. All drugs were assigned into a Multum drug category, even those drugs not found in Multum’s drug database. "Unspecified" drugs were assigned to their respective therapeutic category (e.g., diuretics - unspecified: category id=49, category name= diuretics). "Unknown" drugs (RXDDRUG=55555) were not assigned a therapeutic drug category.

RXDICI1A – RXDICI6C: Multum ingredient therapeutic category id

RXDICN1A – RXDICN6C: Multum ingredient therapeutic category names

Multum uses a "combination" category for some multiple ingredient drugs. These include antihypertensive combinations, antiasthmatic combinations, upper respiratory combinations, psychotherapeutic combinations, bronchodilator combinations, sex hormone combinations, skeletal muscle relaxant combinations, analgesic combinations, narcotic analgesic combinations, antihyperlipidemic combinations, and antidiabetic combinations. This categorization may be sufficient for certain analyses but not for others because it lacks information about the therapeutic effect of the individual ingredients that make up the combination. For example, the drug HYDROCHLOROTHIAZIDE; LOSARTAN is identified as an antihypertensive combination. Therefore, we know that this drug has an antihypertensive drug effect. However, based on this combination category we do not know that the drug’s single ingredients have the therapeutic effects of a diuretic and angiotensin II inhibitor, which is relevant for some analyses. As a result of this unique Multum combination therapeutic category, NCHS decided that, in addition to assigning therapeutic categories to each drug, each drug would also be assigned to the therapeutic categories of its ingredients. In the case of single ingredient drugs, the ingredient therapeutic categories would be the same as the drug therapeutic categories.

This file provides up to six therapeutic ingredient categories for a drug based upon the unique ingredients that make up the drug. It is important to note that the file does not distinguish the therapeutic category of each ingredient. That is, the drug HYDROCHLOROTHIAZIDE; LOSARTAN has one drug therapeutic category (antihypertensive combinations) and two ingredient therapeutic categories (thiazide diuretic and angiotensin II inhibitor). For a combination drug, we do not specify that HYDROCHLOROTHIAZIDE is the thiazide diuretic and LOSARTAN is the angiotensin II inhibitor.

The variables RXDICI1A to RXDICI6C record the unique Multum ingredient therapeutic category id, which is a numeric value from 1 to 433. The variables RXDICN1A to RXDICN6C record the corresponding Multum ingredient therapeutic category name, which is a text entry.

Variable names ending in 'A' are associated with level 1 therapeutic categories, those ending in  'B' are associated with level 2, and those ending in 'C' are associated with level 3.

Data File Structure

The RXQ_DRUG file may be linked to the files on participants’ use of prescription drugs, the NHANES III (1988-1994), 1999-2000, 2001-2002, 2003-2004, 2005-2006, 2007-2008, and 2009-2010 survey cycles, by the variable RXDDRGID.

Currently, RXQ_DRUG contains information on all drugs reported by NHANES participants from 1988 through 2010. New drugs will be appended as they are reported in future data releases. It contains drug (up to 4) and ingredient (up to 6) therapeutic category codes for each drug. It also has a variable that identifies if the drug is made up of a single or multiple ingredients.

Layout of RXQ_DRUG
Position Variable Name Type Length Label
1 RXDDRGID Char 6 GENERIC DRUG CODE
2 RXDDRUG Char 114 GENERIC DRUG NAME
3 RXDINGFL Num 8 SINGLE/MULTIPLE INGREDIENT DRUG
0=Unspecified drug
1=Single ingredient drug
2=Multiple ingredient drug
4 RXDDCI1A Num 8 DRUG CATEGORY ID - CAT 1, LEV 1
5 RXDDCI1B Num 8 DRUG CATEGORY ID - CAT 1, LEV 2
6 RXDDCI1C Num 8 DRUG CATEGORY ID - CAT 1, LEV 3
7 RXDDCI2A Num 8 DRUG CATEGORY ID - CAT 2, LEV 1
8 RXDDCI2B Num 8 DRUG CATEGORY ID - CAT 2, LEV 2
9 RXDDCI2C Num 8 DRUG CATEGORY ID - CAT 2, LEV 3
10 RXDDCI3A Num 8 DRUG CATEGORY ID - CAT 3, LEV 1
11 RXDDCI3B Num 8 DRUG CATEGORY ID - CAT 3, LEV 2
12 RXDDCI3C Num 8 DRUG CATEGORY ID - CAT 3, LEV 3
13 RXDDCI4A Num 8 DRUG CATEGORY ID - CAT 4, LEV 1
14 RXDDCI4B Num 8 DRUG CATEGORY ID - CAT 4, LEV 2
15 RXDDCI4C Num 8 DRUG CATEGORY ID - CAT 4, LEV 3
16 RXDICI1A Num 8 INGREDIENT CATEGORY ID - CAT 1, LEV 1
17 RXDICI1B Num 8 INGREDIENT CATEGORY ID - CAT 1, LEV 2
18 RXDICI1C Num 8 INGREDIENT CATEGORY ID - CAT 1, LEV 3
19 RXDICI2A Num 8 INGREDIENT CATEGORY ID - CAT 2, LEV 1
20 RXDICI2B Num 8 INGREDIENT CATEGORY ID - CAT 2, LEV 2
21 RXDICI2C Num 8 INGREDIENT CATEGORY ID - CAT 2, LEV 3
22 RXDICI3A Num 8 INGREDIENT CATEGORY ID - CAT 3, LEV 1
23 RXDICI3B Num 8 INGREDIENT CATEGORY ID - CAT 3, LEV 2
24 RXDICI3C Num 8 INGREDIENT CATEGORY ID - CAT 3, LEV 3
25 RXDICI4A Num 8 INGREDIENT CATEGORY ID - CAT 4, LEV 1
26 RXDICI4B Num 8 INGREDIENT CATEGORY ID - CAT 4, LEV 2
27 RXDICI4C Num 8 INGREDIENT CATEGORY ID - CAT 4, LEV 3
28 RXDICI5A Num 8 INGREDIENT CATEGORY ID - CAT 5, LEV 1
29 RXDICI5B Num 8 INGREDIENT CATEGORY ID - CAT 5, LEV 2
30 RXDICI5C Num 8 INGREDIENT CATEGORY ID - CAT 5, LEV 3
31 RXDICI6A Num 8 INGREDIENT CATEGORY ID - CAT 6, LEV 1
32 RXDICI6B Num 8 INGREDIENT CATEGORY ID - CAT 6, LEV 2
33 RXDICI6C Num 8 INGREDIENT CATEGORY ID - CAT 6, LEV 3
34 RXDDCN1A Char 60 DRUG CATEGORY NAME - CAT 1, LEV 1
35 RXDDCN1B Char 60 DRUG CATEGORY NAME - CAT 1, LEV 2
36 RXDDCN1C Char 60 DRUG CATEGORY NAME - CAT 1, LEV 3
37 RXDDCN2A Char 60 DRUG CATEGORY NAME - CAT 2, LEV 1
38 RXDDCN2B Char 60 DRUG CATEGORY NAME - CAT 2, LEV 2
39 RXDDCN2C Char 60 DRUG CATEGORY NAME - CAT 2, LEV 3
40 RXDDCN3A Char 60 DRUG CATEGORY NAME - CAT 3, LEV 1
41 RXDDCN3B Char 60 DRUG CATEGORY NAME - CAT 3, LEV 2
42 RXDDCN3C Char 60 DRUG CATEGORY NAME - CAT 3, LEV 3
43 RXDDCN4A Char 60 DRUG CATEGORY NAME - CAT 4, LEV 1
44 RXDDCN4B Char 60 DRUG CATEGORY NAME - CAT 4, LEV 2
45 RXDDCN4C Char 60 DRUG CATEGORY NAME - CAT 4, LEV 3
46 RXDICN1A Char 60 INGREDIENT CATEGORY NAME - CAT 1, LEV 1
47 RXDICN1B Char 60 INGREDIENT CATEGORY NAME - CAT 1, LEV 2
48 RXDICN1C Char 60 INGREDIENT CATEGORY NAME - CAT 1, LEV 3
49 RXDICN2A Char 60 INGREDIENT CATEGORY NAME - CAT 2, LEV 1
50 RXDICN2B Char 60 INGREDIENT CATEGORY NAME - CAT 2, LEV 2
51 RXDICN2C Char 60 INGREDIENT CATEGORY NAME - CAT 2, LEV 3
52 RXDICN3A Char 60 INGREDIENT CATEGORY NAME - CAT 3, LEV 1
53 RXDICN3B Char 60 INGREDIENT CATEGORY NAME - CAT 3, LEV 2
54 RXDICN3C Char 60 INGREDIENT CATEGORY NAME - CAT 3, LEV 3
55 RXDICN4A Char 60 INGREDIENT CATEGORY NAME - CAT 4, LEV 1
56 RXDICN4B Char 60 INGREDIENT CATEGORY NAME - CAT 4, LEV 2
57 RXDICN4C Char 60 INGREDIENT CATEGORY NAME - CAT 4, LEV 3
58 RXDICN5A Char 60 INGREDIENT CATEGORY NAME - CAT 5, LEV 1
59 RXDICN5B Char 60 INGREDIENT CATEGORY NAME - CAT 5, LEV 2
60 RXDICN5C Char 60 INGREDIENT CATEGORY NAME - CAT 5, LEV 3
61 RXDICN6A Char 60 INGREDIENT CATEGORY NAME - CAT 6, LEV 1
62 RXDICN6B Char 60 INGREDIENT CATEGORY NAME - CAT 6, LEV 2
63 RXDICN6C Char 60 INGREDIENT CATEGORY NAME - CAT 6, LEV 3

Analytic Notes

When using the therapeutic categories, it is important to remember that the drug category variables (RXDDCIXX or RXDDCNXX) identify the therapeutic effect(s) of the drug, as a whole. The ingredient therapeutic category variables (RXDICIXX or RXDICNXX) identify the therapeutic effect(s) of the ingredients that make up the drug. Analysts should use the categorization that is appropriate for their analyses.

Analysts should be aware of the "topical agents" therapeutic category (code=133), which includes some anti-infectives, steroids, and respiratory agents that are designated as topical, ophthalmic, otic, and nasal products. Refer to data file, RXQ_DRUG, and the Multum therapeutic classification scheme (Appendix 2). Analyst should also be aware of "combination" therapeutic categories, as mentioned above.

The drug information file is updated along with each cycle of prescription medication data release. Some new therapeutic categories could be added and a few assigned classification levels might be changed (e.g., for alendronate; new three classification levels: 358, metabolic agents [level 1]; 409, bone resorption inhibitors [level 2]; 217, bisphosphonates [level 3]; vs. old two classification levels: 97, hormones [level 1]; 217, bisphosphonates [level 2]). Analyst should use the last revised version for the therapeutic classification.

 

References

Codebook and Frequencies

Appendix 1: Multum Lexicon End-User License Agreement

1. Introduction

A. This License Agreement (the "License") applies to the Multum Lexicon database (the "Database"). This License does not apply to any other products or services of Cerner Multum, Inc. ("Multum"). A "work based on the Database" means either the Database or any derivative work under copyright law; i.e., a work containing the Database or a substantial portion of it, either verbatim or with modifications. A translation of the Database is included without limitation in the term "modification". Each end-user/licensee is addressed herein as "you".

B. Your use of the Database acknowledges acceptance of these restrictions, disclaimers, and limitations. You expressly acknowledge and agree that Multum is not responsible for the results of your decisions resulting from the use of the Database, including, but not limited to, your choosing to seek or not to seek professional medical care, or from choosing or not choosing specific treatment based on the Database.

C. Every effort has been made to ensure that the information provided in the Database is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive.

D. Multum does not assume any responsibility for any aspect of healthcare administered or not administered with the aid of information the Database provides.

2. Terms and Conditions for Copying, Distribution and Modification

A. You may copy and distribute verbatim copies of the Database as you receive it, in any medium, provided that you conspicuously and appropriately publish on each copy an appropriate copyright notice and disclaimer of warranty; keep intact all the notices that refer to this License and to the absence of any warranty; and give any other recipients of the Database a copy of this License (the readme.txt file) along with the Database and anything else that is part of the package, which should be identified.

B. You may modify your copy or copies of the Database or any portion of it to form a derivative work, and copy and distribute such modifications or work under the terms of Section 2.A. above, provided that you also meet all of these conditions:

i) You must cause the modified files to carry prominent notices stating that they are derived from the Multum Lexicon database from Cerner Multum, Inc. and that you changed the files and the date of any change(s).

ii) If you incorporate modified files into a computer program, you must cause it, when started running for interactive use in the most ordinary way, to print or display an announcement including an appropriate copyright notice, a notice that you have modified the Multum Lexicon database from Cerner Multum, Inc., and a notice that there is no warranty (or that you provide the warranty) and telling the user how to view a copy of this License.

C. It is not the intent of this section to claim rights or contest your rights to work written entirely by you; rather, the intent is to exercise the right to control the distribution of derivative or collective works based on the Database.

D. You may copy and distribute the Database (or a work based on it, under Section 2.B.) in an encoded form under the terms of Sections 2.A. and 2.B. above provided that you also do one of the following:

i) Accompany it with the complete corresponding machine-readable plain text, which must be distributed under the terms of Sections 2.A and 2.B. above on a medium customarily used for software interchange; or,

ii) Accompany it with a written offer to give any third party, for no charge, a complete machine-readable copy of the Database (and the entirety of your derivative work based on it, under Section 2.B.), to be distributed under the terms of Sections 2.A. and 2.B. above on a medium customarily used for software interchange.

E. You may not copy, modify, sublicense, or distribute the Database except as expressly provided under this License. Any attempt otherwise to copy, modify, sublicense or distribute the Database will automatically terminate your rights under this License. However, parties who have received copies, or rights, from you under this License will not have their licenses terminated so long as such parties remain in full compliance.

F. You are not required to accept this License. However, nothing else grants you permission to copy, modify or distribute the Database or its derivative works. These actions are prohibited by law if you do not accept this License. Therefore, by copying, modifying or distributing the Database (or any work based on the Database), you indicate your acceptance of this License to do so, and all its terms and conditions for copying, distributing or modifying the Database or works based on it.

G. Each time you redistribute the Database (or any work based on the Database), the recipient automatically receives a license from Multum to copy, distribute or modify the Database subject to these terms and conditions. You may not impose any further restrictions on the recipients' exercise of the rights granted herein. You are not responsible for enforcing compliance by third parties to this License.

3. Disclaimer of Warranties; Limitation of Damages

A. BECAUSE THE DATABASE IS LICENSED FREE OF CHARGE, THERE IS NO WARRANTY FOR THE PROGRAM OR DATA, TO THE EXTENT PERMITTED BY APPLICABLE LAW. EXCEPT WHEN OTHERWISE STATED IN WRITING. MULTUM AND/OR OTHER PARTIES PROVIDE THE DATABASE "AS IS" WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESSED, STATUTORY OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. THE ENTIRE RISK AS TO THE QUALITY AND PERFORMANCE OF THE DATABASE IS WITH YOU. SHOULD THE DATABASE PROVE DEFECTIVE, INCOMPLETE, OR INACCURATE, YOU ASSUME THE RESPONSIBILITY AND COST OF ALL NECESSARY SERVICING, REPAIR OR CORRECTION.

B. IN NO EVENT (UNLESS REQUIRED BY APPLICABLE LAW OR AGREED TO IN WRITING) WILL MULTUM, OR ANY OTHER PARTY WHO MAY MODIFY AND/OR REDISTRIBUTE THE DATABASE AS PERMITTED ABOVE, BE LIABLE FOR ANY SPECIAL, INCIDENTAL, CONSEQUENTIAL, OR INDIRECT DAMAGES, INCLUDING DAMAGES FOR LOSS OF PROFITS, LOSS OF BUSINESS, OR DOWN TIME, EVEN IF MULTUM OR ANY OTHER PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.

C. IN ADDITION, WITHOUT LIMITING THE FOREGOING, THE DATABASE HAS BEEN DESIGNED FOR USE IN THE UNITED STATES ONLY AND COVERS THE DRUG PRODUCTS USED IN PRACTICE IN THE UNITED STATES. MULTUM PROVIDES NO CLINICAL INFORMATION OR CHECKS FOR DRUGS NOT AVAILABLE FOR SALE IN THE UNITED STATES AND CLINICAL PRACTICE PATTERNS OUTSIDE THE UNITED STATES MAY DIFFER SUBSTANTIALLY FROM INFORMATION SUPPLIED BY THE DATABASE. MULTUM DOES NOT WARRANT THAT USES OUTSIDE THE UNITED STATES ARE APPROPRIATE.

D. You acknowledge that updates to the Database are at the sole discretion of Multum. Multum makes no representations or warranties whatsoever, express or implied, with respect to the compatibility of the Database, or future releases thereof, with any computer hardware or software, nor does Multum represent or warrant the continuity of the features or the facilities provided by or through the Database as between various releases thereof.

E. Any warranties expressly provided herein do not apply if: (i) the end-user alters, mishandles or improperly uses, stores or installs all, or any part, of the Database, (ii) the end-user uses, stores or installs the Database on a computer system which fails to meet the specifications provided by Multum, or (iii) the breach of warranty arises out of or in connection with acts or omissions of persons other than Multum.


4. Assumption of Risk, Disclaimer of Liability, Indemnity

A. THE END-USER ASSUMES ALL RISK FOR SELECTION AND USE OF THE DATABASE AND CONTENT PROVIDED THEREON. MULTUM SHALL NOT BE RESPONSIBLE FOR ANY ERRORS, MISSTATEMENTS, INACCURACIES OR OMISSIONS REGARDING CONTENT DELIVERED THROUGH THE DATABASE OR ANY DELAYS IN OR INTERRUPTIONS OF SUCH DELIVERY.

B. THE END-USER ACKNOWLEDGES THAT MULTUM: (A) HAS NO CONTROL OF OR RESPONSIBILITY FORTHE END-USER'S USE OF THE DATABASE OR CONTENT PROVIDED THEREON, (B) HAS NO KNOWLEDGE OF THE SPECIFIC OR UNIQUE CIRCUMSTANCES UNDER WHICH THE DATABASE OR CONTENT PROVIDED THEREON MAY BE USED BY THE END-USER, (C) UNDERTAKES NO OBLIGATION TO SUPPLEMENT OR UPDATE CONTENT OF THE DATABASE, AND (D) HAS NO LIABILITY TO ANY PERSON FOR ANY DATA OR INFORMATION INPUT ON THE DATABASE BY PERSONS OTHER THAN MULTUM.

C. MULTUM SHALL NOT BE LIABLE TO ANY PERSON (INCLUDING BUT NOT LIMITED TO THE END-USER AND PERSONS TREATED BY OR ON BEHALF OF THE END-USER) FOR, AND THE END-USER AGREES TO INDEMNIFY AND HOLD MULTUM HARMLESS FROM ANY CLAIMS, LAWSUITS, PROCEEDINGS, COSTS, ATTORNEYS' FEES, DAMAGES OR OTHER LOSSES (COLLECTIVELY, "LOSSES") ARISING OUT OF OR RELATING TO (A) THE END-USER'S USE OF THE DATABASE OR CONTENT PROVIDED THEREON OR ANY EQUIPMENT FURNISHED IN CONNECTION THEREWITH AND (B) ANY DATA OR INFORMATION INPUT ON THE DATABASE BY END-USER, IN ALL CASES INCLUDING BUT NOT LIMITED TO LOSSES FOR TORT, PERSONAL INJURY, MEDICAL MALPRACTICE OR PRODUCT LIABILITY.


5. Miscellaneous

A. You warrant that you have authority within the organization you identified during registration for the Database to enter into license agreements with other organizations including Multum.

B. You agree that Multum may identify you and/or your organization by name as a "licensee", "licensed user", or "licensing organization" of the Database or a "client" of Multum in Multum's external market communications. You also agree that Multum may issue, if it desires, a press release stating that you and/or your organization have licensed the Database.

C. If conditions are imposed on you (whether by court order, agreement or otherwise) that contradict the conditions of this License, they do not excuse you from the conditions of this License. If you cannot distribute so as to satisfy simultaneously your obligations under this License and any other obligations, then as a consequence you may not distribute the Database at all.

D. If any portion of this License is held invalid or unenforceable under any particular circumstance, the balance of this License is intended to apply and the License as a whole is intended to apply in other circumstances.

E. If the distribution and/or use of the Database is or becomes restricted in certain countries either by patents or by copyrighted interfaces, Multum may add an explicit geographical distribution limitation excluding those countries, so that distribution is permitted only in or among countries not thus excluded. In such case, this License incorporates the limitation as if written in the body of this License.

Multum Lexicon
Copyright (c) 1997, 1998, 1999, 2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007,2008,
2009, 2010, 2011
Cerner Multum, Inc.
2000 South Colorado Blvd, Suite 11000
Denver, Colorado 80222

Document revised December 16, 2010

Appendix 2: Multum Lexicon Therapeutic Classification Scheme

First Level Category ID First Level Category Name Second Level Category ID Second Level Category Name Third Level Category Name Third Level Category ID
1 ANTI-INFECTIVES 2 AMEBICIDES NA NA
1 ANTI-INFECTIVES 3 ANTHELMINTICS NA NA
1 ANTI-INFECTIVES 4 ANTIFUNGALS 235 POLYENES
1 ANTI-INFECTIVES 4 ANTIFUNGALS 236 AZOLE ANTIFUNGALS
1 ANTI-INFECTIVES 4 ANTIFUNGALS 237 MISCELLANEOUS ANTIFUNGALS
1 ANTI-INFECTIVES 5 ANTIMALARIAL AGENTS 238 ANTIMALARIAL QUINOLINES
1 ANTI-INFECTIVES 5 ANTIMALARIAL AGENTS 239 MISCELLANEOUS ANTIMALARIALS
1 ANTI-INFECTIVES 5 ANTIMALARIAL AGENTS 328 ANTIMALARIAL COMBINATIONS
1 ANTI-INFECTIVES 6 ANTITUBERCULOSIS AGENTS 231 NICOTINIC ACID DERIVATIVES
1 ANTI-INFECTIVES 6 ANTITUBERCULOSIS AGENTS 232 RIFAMYCIN DERIVATIVES
1 ANTI-INFECTIVES 6 ANTITUBERCULOSIS AGENTS 234 MISCELLANEOUS ANTITUBERCULOSIS AGENTS
1 ANTI-INFECTIVES 6 ANTITUBERCULOSIS AGENTS 329 ANTITUBERCULOSIS COMBINATIONS
1 ANTI-INFECTIVES 7 ANTIVIRAL AGENTS 175 PROTEASE INHIBITORS
1 ANTI-INFECTIVES 7 ANTIVIRAL AGENTS 176 NRTIS
1 ANTI-INFECTIVES 7 ANTIVIRAL AGENTS 227 NNRTIS
1 ANTI-INFECTIVES 7 ANTIVIRAL AGENTS 228 ADAMANTANE ANTIVIRALS
1 ANTI-INFECTIVES 7 ANTIVIRAL AGENTS 229 PURINE NUCLEOSIDES
1 ANTI-INFECTIVES 7 ANTIVIRAL AGENTS 281 NEURAMINIDASE INHIBITORS
1 ANTI-INFECTIVES 7 ANTIVIRAL AGENTS 327 ANTIVIRAL COMBINATIONS
1 ANTI-INFECTIVES 7 ANTIVIRAL AGENTS 330 ANTIVIRAL INTERFERONS
1 ANTI-INFECTIVES 7 ANTIVIRAL AGENTS 366 INTEGRASE STRAND TRANSFER INHIBITOR
1 ANTI-INFECTIVES 9 CEPHALOSPORINS 159 FIRST GENERATION CEPHALOSPORINS
1 ANTI-INFECTIVES 9 CEPHALOSPORINS 160 SECOND GENERATION CEPHALOSPORINS
1 ANTI-INFECTIVES 9 CEPHALOSPORINS 161 THIRD GENERATION CEPHALOSPORINS
1 ANTI-INFECTIVES 10 LEPROSTATICS NA NA
1 ANTI-INFECTIVES 11 MACROLIDE DERIVATIVES 304 MACROLIDES
1 ANTI-INFECTIVES 11 MACROLIDE DERIVATIVES 305 KETOLIDES
1 ANTI-INFECTIVES 12 MISCELLANEOUS ANTIBIOTICS NA NA
1 ANTI-INFECTIVES 13 PENICILLINS 222 PENICILLINASE RESISTANT PENICILLINS
1 ANTI-INFECTIVES 13 PENICILLINS 223 ANTIPSEUDOMONAL PENICILLINS
1 ANTI-INFECTIVES 13 PENICILLINS 224 AMINOPENICILLINS
1 ANTI-INFECTIVES 13 PENICILLINS 225 BETA-LACTAMASE INHIBITORS
1 ANTI-INFECTIVES 13 PENICILLINS 226 NATURAL PENICILLINS
1 ANTI-INFECTIVES 14 QUINOLONES NA NA
1 ANTI-INFECTIVES 15 SULFONAMIDES NA NA
1 ANTI-INFECTIVES 16 TETRACYCLINES NA NA
1 ANTI-INFECTIVES 17 URINARY ANTI-INFECTIVES NA NA
1 ANTI-INFECTIVES 18 AMINOGLYCOSIDES NA NA
1 ANTI-INFECTIVES 240 LINCOMYCIN DERIVATIVES NA NA
1 ANTI-INFECTIVES 406 GLYCOPEPTIDE ANTIBIOTICS NA NA
20 ANTINEOPLASTICS 21 ALKYLATING AGENTS NA NA
20 ANTINEOPLASTICS 23 ANTIMETABOLITES NA NA
20 ANTINEOPLASTICS 24 ANTINEOPLASTIC HORMONES NA NA
20 ANTINEOPLASTICS 25 MISCELLANEOUS ANTINEOPLASTICS NA NA
20 ANTINEOPLASTICS 26 MITOTIC INHIBITORS NA NA
20 ANTINEOPLASTICS 324 ANTINEOPLASTIC INTERFERONS NA NA
20 ANTINEOPLASTICS 383 ANTINEOPLASTIC DETOXIFYING AGENTS NA NA
20 ANTINEOPLASTICS 397 MULTIKINASE INHIBITORS NA NA
20 ANTINEOPLASTICS 402 VEGF/VEGFR INHIBITORS NA NA
20 ANTINEOPLASTICS 404 EGFR INHIBITORS NA NA
20 ANTINEOPLASTICS 405 HER2 INHIBITORS NA NA
28 BIOLOGICALS 32 COLONY STIMULATING FACTORS NA NA
28 BIOLOGICALS 34 IN VIVO DIAGNOSTIC BIOLOGICALS NA NA
28 BIOLOGICALS 36 RECOMBINANT HUMAN ERYTHROPOIETINS NA NA
40 CARDIOVASCULAR AGENTS 41 AGENTS FOR HYPERTENSIVE EMERGENCIES NA NA
40 CARDIOVASCULAR AGENTS 42 ANGIOTENSIN CONVERTING ENZYME INHIBITORS NA NA
40 CARDIOVASCULAR AGENTS 43 ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING NA NA
40 CARDIOVASCULAR AGENTS 44 ANTIADRENERGIC AGENTS, CENTRALLY ACTING NA NA
40 CARDIOVASCULAR AGENTS 45 ANTIANGINAL AGENTS NA NA
40 CARDIOVASCULAR AGENTS 46 ANTIARRHYTHMIC AGENTS NA NA
40 CARDIOVASCULAR AGENTS 46 ANTIARRHYTHMIC AGENTS 385 GROUP I ANTIARRHYTHMICS
40 CARDIOVASCULAR AGENTS 46 ANTIARRHYTHMIC AGENTS 386 GROUP II ANTIARRHYTHMICS
40 CARDIOVASCULAR AGENTS 46 ANTIARRHYTHMIC AGENTS 387 GROUP III ANTIARRHYTHMICS
40 CARDIOVASCULAR AGENTS 46 ANTIARRHYTHMIC AGENTS 388 GROUP IV ANTIARRHYTHMICS
40 CARDIOVASCULAR AGENTS 46 ANTIARRHYTHMIC AGENTS 389 GROUP V ANTIARRHYTHMICS
40 CARDIOVASCULAR AGENTS 47 BETA-ADRENERGIC BLOCKING AGENTS NA NA
40 CARDIOVASCULAR AGENTS 47 BETA-ADRENERGIC BLOCKING AGENTS 274 CARDIOSELECTIVE BETA BLOCKERS
40 CARDIOVASCULAR AGENTS 47 BETA-ADRENERGIC BLOCKING AGENTS 275 NON-CARDIOSELECTIVE BETA BLOCKERS
40 CARDIOVASCULAR AGENTS 48 CALCIUM CHANNEL BLOCKING AGENTS NA NA
40 CARDIOVASCULAR AGENTS 49 DIURETICS NA NA
40 CARDIOVASCULAR AGENTS 49 DIURETICS 154 LOOP DIURETICS
40 CARDIOVASCULAR AGENTS 49 DIURETICS 155 POTASSIUM-SPARING DIURETICS
40 CARDIOVASCULAR AGENTS 49 DIURETICS 156 THIAZIDE DIURETICS
40 CARDIOVASCULAR AGENTS 49 DIURETICS 157 CARBONIC ANHYDRASE INHIBITORS
40 CARDIOVASCULAR AGENTS 50 INOTROPIC AGENTS NA NA
40 CARDIOVASCULAR AGENTS 51 MISCELLANEOUS CARDIOVASCULAR AGENTS NA NA
40 CARDIOVASCULAR AGENTS 52 PERIPHERAL VASODILATORS NA NA
40 CARDIOVASCULAR AGENTS 53 VASODILATORS NA NA
40 CARDIOVASCULAR AGENTS 54 VASOPRESSORS NA NA
40 CARDIOVASCULAR AGENTS 55 ANTIHYPERTENSIVE COMBINATIONS NA NA
40 CARDIOVASCULAR AGENTS 56 ANGIOTENSIN II INHIBITORS NA NA
40 CARDIOVASCULAR AGENTS 303 AGENTS FOR PULMONARY HYPERTENSION NA NA
40 CARDIOVASCULAR AGENTS 340 ALDOSTERONE RECEPTOR ANTAGONISTS NA NA
40 CARDIOVASCULAR AGENTS 342 RENIN INHIBITORS NA NA
40 CARDIOVASCULAR AGENTS 430 ANTICHOLINERGIC CHRONOTROPIC AGENTS NA NA
40 CARDIOVASCULAR AGENTS 433 CATECHOLAMINES NA NA
57 CENTRAL NERVOUS SYSTEM AGENTS 58 ANALGESICS NA NA
57 CENTRAL NERVOUS SYSTEM AGENTS 58 ANALGESICS 59 MISCELLANEOUS ANALGESICS
57 CENTRAL NERVOUS SYSTEM AGENTS 58 ANALGESICS 60 NARCOTIC ANALGESICS
57 CENTRAL NERVOUS SYSTEM AGENTS 58 ANALGESICS 61 NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
57 CENTRAL NERVOUS SYSTEM AGENTS 58 ANALGESICS 62 SALICYLATES
57 CENTRAL NERVOUS SYSTEM AGENTS 58 ANALGESICS 63 ANALGESIC COMBINATIONS
57 CENTRAL NERVOUS SYSTEM AGENTS 58 ANALGESICS 191 NARCOTIC ANALGESIC COMBINATIONS
57 CENTRAL NERVOUS SYSTEM AGENTS 58 ANALGESICS 193 ANTIMIGRAINE AGENTS
57 CENTRAL NERVOUS SYSTEM AGENTS 58 ANALGESICS 278 COX-2 INHIBITORS
57 CENTRAL NERVOUS SYSTEM AGENTS 64 ANTICONVULSANTS 199 HYDANTOIN ANTICONVULSANTS
57 CENTRAL NERVOUS SYSTEM AGENTS 64 ANTICONVULSANTS 200 SUCCINIMIDE ANTICONVULSANTS
57 CENTRAL NERVOUS SYSTEM AGENTS 64 ANTICONVULSANTS 201 BARBITURATE ANTICONVULSANTS
57 CENTRAL NERVOUS SYSTEM AGENTS 64 ANTICONVULSANTS 203 BENZODIAZEPINE ANTICONVULSANTS
57 CENTRAL NERVOUS SYSTEM AGENTS 64 ANTICONVULSANTS 204 MISCELLANEOUS ANTICONVULSANTS
57 CENTRAL NERVOUS SYSTEM AGENTS 64 ANTICONVULSANTS 311 DIBENZAZEPINE ANTICONVULSANTS
57 CENTRAL NERVOUS SYSTEM AGENTS 64 ANTICONVULSANTS 345 FATTY ACID DERIVATIVE ANTICONVULSANTS
57 CENTRAL NERVOUS SYSTEM AGENTS 64 ANTICONVULSANTS 346 GAMMA-AMINOBUTYRIC ACID REUPTAKE INHIBITORS
57 CENTRAL NERVOUS SYSTEM AGENTS 64 ANTICONVULSANTS 347 GAMMA-AMINOBUTYRIC ACID ANALOGS
57 CENTRAL NERVOUS SYSTEM AGENTS 64 ANTICONVULSANTS 348 TRIAZINE ANTICONVULSANTS
57 CENTRAL NERVOUS SYSTEM AGENTS 64 ANTICONVULSANTS 350 PYRROLIDINE ANTICONVULSANTS
57 CENTRAL NERVOUS SYSTEM AGENTS 64 ANTICONVULSANTS 351 CARBONIC ANHYDRASE INHIBITOR ANTICONVULSANTS
57 CENTRAL NERVOUS SYSTEM AGENTS 65 ANTIEMETIC/ANTIVERTIGO AGENTS 195 5HT3 RECEPTOR ANTAGONISTS
57 CENTRAL NERVOUS SYSTEM AGENTS 65 ANTIEMETIC/ANTIVERTIGO AGENTS 196 PHENOTHIAZINE ANTIEMETICS
57 CENTRAL NERVOUS SYSTEM AGENTS 65 ANTIEMETIC/ANTIVERTIGO AGENTS 197 ANTICHOLINERGIC ANTIEMETICS
57 CENTRAL NERVOUS SYSTEM AGENTS 65 ANTIEMETIC/ANTIVERTIGO AGENTS 198 MISCELLANEOUS ANTIEMETICS
57 CENTRAL NERVOUS SYSTEM AGENTS 66 ANTIPARKINSON AGENTS 205 ANTICHOLINERGIC ANTIPARKINSON AGENTS
57 CENTRAL NERVOUS SYSTEM AGENTS 66 ANTIPARKINSON AGENTS 276 DOPAMINERGIC ANTIPARKINSONISM AGENTS
57 CENTRAL NERVOUS SYSTEM AGENTS 67 ANXIOLYTICS, SEDATIVES, AND HYPNOTICS NA NA
57 CENTRAL NERVOUS SYSTEM AGENTS 67 ANXIOLYTICS, SEDATIVES, AND HYPNOTICS 68 BARBITURATES
57 CENTRAL NERVOUS SYSTEM AGENTS 67 ANXIOLYTICS, SEDATIVES, AND HYPNOTICS 69 BENZODIAZEPINES
57 CENTRAL NERVOUS SYSTEM AGENTS 67 ANXIOLYTICS, SEDATIVES, AND HYPNOTICS 70 MISCELLANEOUS ANXIOLYTICS, SEDATIVES AND HYPNOTICS
57 CENTRAL NERVOUS SYSTEM AGENTS 71 CNS STIMULANTS NA NA
57 CENTRAL NERVOUS SYSTEM AGENTS 73 MUSCLE RELAXANTS NA NA
57 CENTRAL NERVOUS SYSTEM AGENTS 73 MUSCLE RELAXANTS 178 SKELETAL MUSCLE RELAXANTS
57 CENTRAL NERVOUS SYSTEM AGENTS 73 MUSCLE RELAXANTS 179 SKELETAL MUSCLE RELAXANT COMBINATIONS
57 CENTRAL NERVOUS SYSTEM AGENTS 80 MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS NA NA
57 CENTRAL NERVOUS SYSTEM AGENTS 253 ANOREXIANTS NA NA
57 CENTRAL NERVOUS SYSTEM AGENTS 312 CHOLINERGIC AGONISTS NA NA
57 CENTRAL NERVOUS SYSTEM AGENTS 313 CHOLINESTERASE INHIBITORS NA NA
57 CENTRAL NERVOUS SYSTEM AGENTS 378 DRUGS USED IN ALCOHOL DEPENDENCE NA NA
81 COAGULATION MODIFIERS 82 ANTICOAGULANTS 261 HEPARINS
81 COAGULATION MODIFIERS 82 ANTICOAGULANTS 262 COUMARINS AND INDANEDIONES
81 COAGULATION MODIFIERS 83 ANTIPLATELET AGENTS 211 PLATELET AGGREGATION INHIBITORS
81 COAGULATION MODIFIERS 85 MISCELLANEOUS COAGULATION MODIFIERS NA NA
87 GASTROINTESTINAL AGENTS 88 ANTACIDS NA NA
87 GASTROINTESTINAL AGENTS 90 ANTIDIARRHEALS NA NA
87 GASTROINTESTINAL AGENTS 91 DIGESTIVE ENZYMES NA NA
87 GASTROINTESTINAL AGENTS 92 GALLSTONE SOLUBILIZING AGENTS NA NA
87 GASTROINTESTINAL AGENTS 93 GI STIMULANTS NA NA
87 GASTROINTESTINAL AGENTS 94 H2 ANTAGONISTS NA NA
87 GASTROINTESTINAL AGENTS 95 LAXATIVES NA NA
87 GASTROINTESTINAL AGENTS 96 MISCELLANEOUS GI AGENTS NA NA
87 GASTROINTESTINAL AGENTS 272 PROTON PUMP INHIBITORS NA NA
87 GASTROINTESTINAL AGENTS 277 5-AMINOSALICYLATES NA NA
87 GASTROINTESTINAL AGENTS 354 H. PYLORI ERADICATION AGENTS NA NA
87 GASTROINTESTINAL AGENTS 355 FUNCTIONAL BOWEL DISORDER AGENTS NA NA
87 GASTROINTESTINAL AGENTS 355 FUNCTIONAL BOWEL DISORDER AGENTS 89 ANTICHOLINERGICS/ANTISPASMODICS
87 GASTROINTESTINAL AGENTS 355 FUNCTIONAL BOWEL DISORDER AGENTS 356 SEROTONINERGIC NEUROENTERIC MODULATORS
87 GASTROINTESTINAL AGENTS 355 FUNCTIONAL BOWEL DISORDER AGENTS 362 CHLORIDE CHANNEL ACTIVATORS
97 HORMONES/HORMONE MODIFIERS 98 ADRENAL CORTICAL STEROIDS 301 GLUCOCORTICOIDS
97 HORMONES/HORMONE MODIFIERS 98 ADRENAL CORTICAL STEROIDS 302 MINERALOCORTICOIDS
97 HORMONES/HORMONE MODIFIERS 101 SEX HORMONES 102 CONTRACEPTIVES
97 HORMONES/HORMONE MODIFIERS 101 SEX HORMONES 182 ANDROGENS AND ANABOLIC STEROIDS
97 HORMONES/HORMONE MODIFIERS 101 SEX HORMONES 183 ESTROGENS
97 HORMONES/HORMONE MODIFIERS 101 SEX HORMONES 185 PROGESTINS
97 HORMONES/HORMONE MODIFIERS 101 SEX HORMONES 186 SEX HORMONE COMBINATIONS
97 HORMONES/HORMONE MODIFIERS 101 SEX HORMONES 187 MISCELLANEOUS SEX HORMONES
97 HORMONES/HORMONE MODIFIERS 101 SEX HORMONES 279 GONADOTROPIN-RELEASING HORMONE AND ANALOGS
97 HORMONES/HORMONE MODIFIERS 103 THYROID HORMONES NA NA
97 HORMONES/HORMONE MODIFIERS 288 5-ALPHA-REDUCTASE INHIBITORS NA NA
97 HORMONES/HORMONE MODIFIERS 295 GROWTH HORMONES NA NA
97 HORMONES/HORMONE MODIFIERS 377 PROLACTIN INHIBITORS NA NA
97 HORMONES/HORMONE MODIFIERS 411 CALCITONIN NA NA
97 HORMONES/HORMONE MODIFIERS 413 ANTIGONADOTROPIC AGENTS NA NA
97 HORMONES/HORMONE MODIFIERS 414 ANTIDIURETIC HORMONES NA NA
97 HORMONES/HORMONE MODIFIERS 416 SOMATOSTATIN AND SOMATOSTATIN ANALOGS NA NA
97 HORMONES/HORMONE MODIFIERS 417 SELECTIVE ESTROGEN RECEPTOR MODULATORS NA NA
97 HORMONES/HORMONE MODIFIERS 418 PARATHYROID HORMONE AND ANALOGS NA NA
97 HORMONES/HORMONE MODIFIERS 420 ANTIANDROGENS NA NA
97 HORMONES/HORMONE MODIFIERS 422 ANTITHYROID AGENTS NA NA
97 HORMONES/HORMONE MODIFIERS 423 AROMATASE INHIBITORS NA NA
97 HORMONES/HORMONE MODIFIERS 426 SYNTHETIC OVULATION STIMULANTS NA NA
105 MISCELLANEOUS AGENTS 106 ANTIDOTES NA NA
105 MISCELLANEOUS AGENTS 107 CHELATING AGENTS NA NA
105 MISCELLANEOUS AGENTS 108 CHOLINERGIC MUSCLE STIMULANTS NA NA
105 MISCELLANEOUS AGENTS 109 LOCAL INJECTABLE ANESTHETICS NA NA
105 MISCELLANEOUS AGENTS 110 MISCELLANEOUS UNCATEGORIZED AGENTS NA NA
105 MISCELLANEOUS AGENTS 111 PSORALENS NA NA
105 MISCELLANEOUS AGENTS 114 ILLICIT (STREET) DRUGS NA NA
105 MISCELLANEOUS AGENTS 192 ANTIRHEUMATICS NA NA
105 MISCELLANEOUS AGENTS 270 ANTIPSORIATICS NA NA
105 MISCELLANEOUS AGENTS 320 SMOKING CESSATION AGENTS NA NA
113 GENITOURINARY TRACT AGENTS 263 IMPOTENCE AGENTS NA NA
113 GENITOURINARY TRACT AGENTS 264 URINARY ANTISPASMODICS NA NA
113 GENITOURINARY TRACT AGENTS 265 URINARY PH MODIFIERS NA NA
113 GENITOURINARY TRACT AGENTS 266 MISCELLANEOUS GENITOURINARY TRACT AGENTS NA NA
113 GENITOURINARY TRACT AGENTS 412 UTEROTONIC AGENTS NA NA
113 GENITOURINARY TRACT AGENTS 427 TOCOLYTIC AGENTS NA NA
115 NUTRITIONAL PRODUCTS 116 IRON PRODUCTS NA NA
115 NUTRITIONAL PRODUCTS 117 MINERALS AND ELECTROLYTES NA NA
115 NUTRITIONAL PRODUCTS 118 ORAL NUTRITIONAL SUPPLEMENTS NA NA
115 NUTRITIONAL PRODUCTS 119 VITAMINS NA NA
115 NUTRITIONAL PRODUCTS 121 INTRAVENOUS NUTRITIONAL PRODUCTS NA NA
122 RESPIRATORY AGENTS 123 ANTIHISTAMINES NA NA
122 RESPIRATORY AGENTS 124 ANTITUSSIVES NA NA
122 RESPIRATORY AGENTS 125 BRONCHODILATORS 126 METHYLXANTHINES
122 RESPIRATORY AGENTS 125 BRONCHODILATORS 180 ADRENERGIC BRONCHODILATORS
122 RESPIRATORY AGENTS 125 BRONCHODILATORS 181 BRONCHODILATOR COMBINATIONS
122 RESPIRATORY AGENTS 125 BRONCHODILATORS 299 ANTICHOLINERGIC BRONCHODILATORS
122 RESPIRATORY AGENTS 127 DECONGESTANTS NA NA
122 RESPIRATORY AGENTS 128 EXPECTORANTS NA NA
122 RESPIRATORY AGENTS 129 MISCELLANEOUS RESPIRATORY AGENTS NA NA
122 RESPIRATORY AGENTS 130 RESPIRATORY INHALANT PRODUCTS NA NA
122 RESPIRATORY AGENTS 130 RESPIRATORY INHALANT PRODUCTS 296 INHALED CORTICOSTEROIDS
122 RESPIRATORY AGENTS 130 RESPIRATORY INHALANT PRODUCTS 297 MUCOLYTICS
122 RESPIRATORY AGENTS 130 RESPIRATORY INHALANT PRODUCTS 298 MAST CELL STABILIZERS
122 RESPIRATORY AGENTS 130 RESPIRATORY INHALANT PRODUCTS 407 INHALED ANTI-INFECTIVES
122 RESPIRATORY AGENTS 131 ANTIASTHMATIC COMBINATIONS NA NA
122 RESPIRATORY AGENTS 132 UPPER RESPIRATORY COMBINATIONS NA NA
122 RESPIRATORY AGENTS 243 LEUKOTRIENE MODIFIERS NA NA
133 TOPICAL AGENTS 134 ANORECTAL PREPARATIONS NA NA
133 TOPICAL AGENTS 135 ANTISEPTIC AND GERMICIDES NA NA
133 TOPICAL AGENTS 136 DERMATOLOGICAL AGENTS NA NA
133 TOPICAL AGENTS 136 DERMATOLOGICAL AGENTS 137 TOPICAL ANTI-INFECTIVES
133 TOPICAL AGENTS 136 DERMATOLOGICAL AGENTS 138 TOPICAL STEROIDS
133 TOPICAL AGENTS 136 DERMATOLOGICAL AGENTS 139 TOPICAL ANESTHETICS
133 TOPICAL AGENTS 136 DERMATOLOGICAL AGENTS 140 MISCELLANEOUS TOPICAL AGENTS
133 TOPICAL AGENTS 136 DERMATOLOGICAL AGENTS 141 TOPICAL STEROIDS WITH ANTI-INFECTIVES
133 TOPICAL AGENTS 136 DERMATOLOGICAL AGENTS 143 TOPICAL ACNE AGENTS
133 TOPICAL AGENTS 136 DERMATOLOGICAL AGENTS 144 TOPICAL ANTIPSORIATICS
133 TOPICAL AGENTS 136 DERMATOLOGICAL AGENTS 248 TOPICAL EMOLLIENTS
133 TOPICAL AGENTS 136 DERMATOLOGICAL AGENTS 290 TOPICAL ANTIBIOTICS
133 TOPICAL AGENTS 136 DERMATOLOGICAL AGENTS 291 TOPICAL ANTIVIRALS
133 TOPICAL AGENTS 136 DERMATOLOGICAL AGENTS 292 TOPICAL ANTIFUNGALS
133 TOPICAL AGENTS 136 DERMATOLOGICAL AGENTS 380 TOPICAL DEBRIDING AGENTS
133 TOPICAL AGENTS 136 DERMATOLOGICAL AGENTS 381 TOPICAL DEPIGMENTING AGENTS
133 TOPICAL AGENTS 136 DERMATOLOGICAL AGENTS 395 TOPICAL KERATOLYTICS
133 TOPICAL AGENTS 146 MOUTH AND THROAT PRODUCTS NA NA
133 TOPICAL AGENTS 147 OPHTHALMIC PREPARATIONS NA NA
133 TOPICAL AGENTS 147 OPHTHALMIC PREPARATIONS 163 OPHTHALMIC ANTI-INFECTIVES
133 TOPICAL AGENTS 147 OPHTHALMIC PREPARATIONS 164 OPHTHALMIC GLAUCOMA AGENTS
133 TOPICAL AGENTS 147 OPHTHALMIC PREPARATIONS 165 OPHTHALMIC STEROIDS
133 TOPICAL AGENTS 147 OPHTHALMIC PREPARATIONS 166 OPHTHALMIC STEROIDS WITH ANTI-INFECTIVES
133 TOPICAL AGENTS 147 OPHTHALMIC PREPARATIONS 167 OPHTHALMIC ANTI-INFLAMMATORY AGENTS
133 TOPICAL AGENTS 147 OPHTHALMIC PREPARATIONS 168 OPHTHALMIC LUBRICANTS AND IRRIGATIONS
133 TOPICAL AGENTS 147 OPHTHALMIC PREPARATIONS 169 MISCELLANEOUS OPHTHALMIC AGENTS
133 TOPICAL AGENTS 147 OPHTHALMIC PREPARATIONS 267 OPHTHALMIC ANTIHISTAMINES AND DECONGESTANTS
133 TOPICAL AGENTS 147 OPHTHALMIC PREPARATIONS 286 MYDRIATICS
133 TOPICAL AGENTS 147 OPHTHALMIC PREPARATIONS 287 OPHTHALMIC ANESTHETICS
133 TOPICAL AGENTS 147 OPHTHALMIC PREPARATIONS 321 OPHTHALMIC DIAGNOSTIC AGENTS
133 TOPICAL AGENTS 148 OTIC PREPARATIONS NA NA
133 TOPICAL AGENTS 148 OTIC PREPARATIONS 170 OTIC ANTI-INFECTIVES
133 TOPICAL AGENTS 148 OTIC PREPARATIONS 171 OTIC STEROIDS WITH ANTI-INFECTIVES
133 TOPICAL AGENTS 148 OTIC PREPARATIONS 172 MISCELLANEOUS OTIC AGENTS
133 TOPICAL AGENTS 148 OTIC PREPARATIONS 370 OTIC STEROIDS
133 TOPICAL AGENTS 148 OTIC PREPARATIONS 392 OTIC ANESTHETICS
133 TOPICAL AGENTS 148 OTIC PREPARATIONS 393 CERUMENOLYTICS
133 TOPICAL AGENTS 151 VAGINAL PREPARATIONS 268 VAGINAL ANTI-INFECTIVES
133 TOPICAL AGENTS 151 VAGINAL PREPARATIONS 269 MISCELLANEOUS VAGINAL AGENTS
133 TOPICAL AGENTS 247 NASAL PREPARATIONS 245 NASAL STEROIDS
133 TOPICAL AGENTS 247 NASAL PREPARATIONS 246 NASAL ANTIHISTAMINES AND DECONGESTANTS
153 PLASMA EXPANDERS NA NA NA NA
218 ALTERNATIVE MEDICINES 219 NUTRACEUTICAL PRODUCTS NA NA
242 PSYCHOTHERAPEUTIC AGENTS 249 ANTIDEPRESSANTS NA NA
242 PSYCHOTHERAPEUTIC AGENTS 249 ANTIDEPRESSANTS 76 MISCELLANEOUS ANTIDEPRESSANTS
242 PSYCHOTHERAPEUTIC AGENTS 249 ANTIDEPRESSANTS 208 SSRI ANTIDEPRESSANTS
242 PSYCHOTHERAPEUTIC AGENTS 249 ANTIDEPRESSANTS 209 TRICYCLIC ANTIDEPRESSANTS
242 PSYCHOTHERAPEUTIC AGENTS 249 ANTIDEPRESSANTS 250 MONOAMINE OXIDASE INHIBITORS
242 PSYCHOTHERAPEUTIC AGENTS 249 ANTIDEPRESSANTS 306 PHENYLPIPERAZINE ANTIDEPRESSANTS
242 PSYCHOTHERAPEUTIC AGENTS 249 ANTIDEPRESSANTS 307 TETRACYCLIC ANTIDEPRESSANTS
242 PSYCHOTHERAPEUTIC AGENTS 249 ANTIDEPRESSANTS 308 SSNRI ANTIDEPRESSANTS
242 PSYCHOTHERAPEUTIC AGENTS 251 ANTIPSYCHOTICS NA NA
242 PSYCHOTHERAPEUTIC AGENTS 251 ANTIPSYCHOTICS 77 MISCELLANEOUS ANTIPSYCHOTIC AGENTS
242 PSYCHOTHERAPEUTIC AGENTS 251 ANTIPSYCHOTICS 79 PSYCHOTHERAPEUTIC COMBINATIONS
242 PSYCHOTHERAPEUTIC AGENTS 251 ANTIPSYCHOTICS 210 PHENOTHIAZINE ANTIPSYCHOTICS
242 PSYCHOTHERAPEUTIC AGENTS 251 ANTIPSYCHOTICS 280 THIOXANTHENES
242 PSYCHOTHERAPEUTIC AGENTS 251 ANTIPSYCHOTICS 341 ATYPICAL ANTIPSYCHOTICS
254 IMMUNOLOGIC AGENTS 33 IMMUNE GLOBULINS NA NA
254 IMMUNOLOGIC AGENTS 39 MISCELLANEOUS BIOLOGICALS NA NA
254 IMMUNOLOGIC AGENTS 104 IMMUNOSUPPRESSIVE AGENTS NA NA
254 IMMUNOLOGIC AGENTS 256 INTERFERONS NA NA
254 IMMUNOLOGIC AGENTS 257 IMMUNOSUPPRESSIVE MONOCLONAL ANTIBODIES NA NA
331 RADIOLOGIC AGENTS 332 RADIOLOGIC ADJUNCTS 374 CARDIAC STRESSING AGENTS
358 METABOLIC AGENTS 19 ANTIHYPERLIPIDEMIC AGENTS NA NA
358 METABOLIC AGENTS 19 ANTIHYPERLIPIDEMIC AGENTS 173 HMG-COA REDUCTASE INHIBITORS
358 METABOLIC AGENTS 19 ANTIHYPERLIPIDEMIC AGENTS 174 MISCELLANEOUS ANTIHYPERLIPIDEMIC AGENTS
358 METABOLIC AGENTS 19 ANTIHYPERLIPIDEMIC AGENTS 241 FIBRIC ACID DERIVATIVES
358 METABOLIC AGENTS 19 ANTIHYPERLIPIDEMIC AGENTS 252 BILE ACID SEQUESTRANTS
358 METABOLIC AGENTS 19 ANTIHYPERLIPIDEMIC AGENTS 316 CHOLESTEROL ABSORPTION INHIBITORS
358 METABOLIC AGENTS 19 ANTIHYPERLIPIDEMIC AGENTS 317 ANTIHYPERLIPIDEMIC COMBINATIONS
358 METABOLIC AGENTS 99 ANTIDIABETIC AGENTS NA NA
358 METABOLIC AGENTS 99 ANTIDIABETIC AGENTS 213 SULFONYLUREAS
358 METABOLIC AGENTS 99 ANTIDIABETIC AGENTS 214 BIGUANIDES
358 METABOLIC AGENTS 99 ANTIDIABETIC AGENTS 215 INSULIN
358 METABOLIC AGENTS 99 ANTIDIABETIC AGENTS 216 ALPHA-GLUCOSIDASE INHIBITORS
358 METABOLIC AGENTS 99 ANTIDIABETIC AGENTS 271 THIAZOLIDINEDIONES
358 METABOLIC AGENTS 99 ANTIDIABETIC AGENTS 282 MEGLITINIDES
358 METABOLIC AGENTS 99 ANTIDIABETIC AGENTS 314 ANTIDIABETIC COMBINATIONS
358 METABOLIC AGENTS 99 ANTIDIABETIC AGENTS 371 DIPEPTIDYL PEPTIDASE 4 INHIBITORS
358 METABOLIC AGENTS 99 ANTIDIABETIC AGENTS 372 AMYLIN ANALOGS
358 METABOLIC AGENTS 99 ANTIDIABETIC AGENTS 373 INCRETIN MIMETICS
358 METABOLIC AGENTS 194 ANTIGOUT AGENTS NA NA
358 METABOLIC AGENTS 289 ANTIHYPERURICEMIC AGENTS NA NA
358 METABOLIC AGENTS 293 GLUCOSE ELEVATING AGENTS NA NA
358 METABOLIC AGENTS 359 PERIPHERALLY ACTING ANTIOBESITY AGENTS NA NA
358 METABOLIC AGENTS 361 MISCELLANEOUS METABOLIC AGENTS NA NA
358 METABOLIC AGENTS 409 BONE RESORPTION INHIBITORS 217 BISPHOSPHONATES